The usefulness of selected sequences of magnetic resonance imaging in a diagnostic model for Crohn’s disease

Introduction We hypothesized that, based on magnetic resonance enterography (MRE) and the apparent diffusion coefficient (ADC), measured in the affected parts of the intestine, it is possible to effectively differentiate active and chronic phases of Crohn’s disease. Aim To create a multidimensional diagnostic model for differentiating between the phases of Crohn’s disease. Material and methods This study included 125 patients – 55 women (aged 19 to 66 years) and 70 men (aged 12 to 67 years) – who underwent MRE and ADC measurement for the first time. Results The group of potential explanatory variables comprised 11 variables, including the thickness and length of the occupied section, number of lymph nodes, layered bowel wall enhancement, total transitions on fat tissue, and features of restricted diffusion. The final discrimination model was based on 2 variables: ADC (A) and layered bowel wall enhancement (W). Active Crohn’s disease was defined as –6.339 + 4.747 × W + 0.008 × A, while chronic Crohn’s disease was defined as –11.365 + 2.812 × W + 0.012 × A. Definitive diagnosis was based on histological examination of material collected during ileocolonoscopy in 96 patients, surgery with subsequent histopathological examination in 17 patients, and capsule endoscopy in 12 patients. Conclusions The predictive model described here could identify the active form of Crohn’s disease with a probability of 93.06% and the chronic form with a probability of 75.57%. The use of classic MRE layered bowel wall enhancement and a DWI-based ADC metric eliminates the main shortcomings of both approaches.

[1]  E. Zerem,et al.  Significance of diffusion weighted imaging (DWI) as an improving factor in contrast enhanced magnetic resonance imaging (MRI) enterography in evaluation of patients with Crohn's disease. , 2018, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina.

[2]  L. Peyrin-Biroulet,et al.  Early intervention in Crohn’s disease: towards disease modification trials , 2017, Gut.

[3]  C. Langner,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.

[4]  Zi-Ping Li,et al.  Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study , 2017, Inflammatory bowel diseases.

[5]  C. Reinhold,et al.  Diffusion‐weighted MRI in Crohn's disease: Current status and recommendations , 2016, Journal of magnetic resonance imaging : JMRI.

[6]  S. Park DWI at MR Enterography for Evaluating Bowel Inflammation in Crohn Disease. , 2016, AJR. American journal of roentgenology.

[7]  F. Qi,et al.  Utility of the diffusion-weighted imaging for activity evaluation in Crohn’s disease patients underwent magnetic resonance enterography , 2015, BMC Gastroenterology.

[8]  L. Boyer,et al.  Diffusion-Weighted Magnetic Resonance Imaging in Ileocolonic Crohn's Disease: Validation of Quantitative Index of Activity , 2014, The American Journal of Gastroenterology.

[9]  R. Vinci,et al.  Assessment of activity of Crohn’s disease of the ileum and large bowel: proposal for a new multiparameter MR enterography score , 2013, La radiologia medica.

[10]  Alexander Pitman,et al.  Relative efficacy of different MRI signs in diagnosing active Crohn's disease, compared against a histological gold standard , 2011, Journal of medical imaging and radiation oncology.

[11]  Pek-Lan Khong,et al.  Radiation dose and cancer risk from pediatric CT examinations on 64-slice CT: a phantom study. , 2010, European journal of radiology.

[12]  Aytekin Oto,et al.  Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease. , 2009, Academic radiology.

[13]  K. Ohtomo,et al.  Free‐breathing diffusion‐weighted imaging for the assessment of inflammatory activity in Crohn's disease , 2009, Journal of magnetic resonance imaging : JMRI.

[14]  G. Perrone,et al.  Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease , 2008, Abdominal Imaging.

[15]  M. Vos,et al.  Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial , 2008, The Lancet.

[16]  D. Koh,et al.  MR imaging evaluation of the activity of Crohn's disease. , 2001, AJR. American journal of roentgenology.

[17]  European Crohn’s and Colitis Organisation , 2019, The Grants Register 2022.

[18]  M. Gee,et al.  Value of diffusion-weighted imaging when added to magnetic resonance enterographic evaluation of Crohn disease in children , 2015, Pediatric Radiology.

[19]  I. Arnott,et al.  Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease? , 2002, Alimentary pharmacology & therapeutics.